CST3 and neurodegenerative disease: Accumulating evidence has suggested that cystatin C was significantly associated with cognitive impairment in older adults, as well as patients with neurodegenerative diseases (Cathcart et al., 2005; Chen et al., 2015; Cui et al., 2020; Nair et al., 2020; Yang et al., 2021).